Supplementary Figure S3 from Preclinical Development of CAR T Cells with Antigen-Inducible IL18 Enforcement to Treat GD2-Positive Solid Cancers

Tolerability
DOI: 10.1158/1078-0432.26711199.v1 Publication Date: 2024-08-15T07:31:15Z